Literature DB >> 29131274

Expression level and clinical significance of IL-2, IL-6 and TGF-β in elderly patients with goiter and hyperthyroidism.

L-F Lv1, H-Y Jia, H-F Zhang, Y-X Hu.   

Abstract

OBJECTIVE: To investigate the level of expression and the clinical significance of IL-2 (interleukin-2), IL-6 (interleukin-6) and TGF-β (transforming growth factor-β) in elderly patients with goiter and hyperthyroidism. PATIENTS AND METHODS: Gender, age, course of disease, BMI (Body Mass Index), serum FT3 (Free triiodothyronine-3), FT4 (Free triiodothyronine-4), TT3 (Total triiodothyronine-3), TT4 (Total triiodothyronine-4), TSH (Thyroid Stimulating Hormone) and clinical manifestations on admission and other general clinical data and laboratory examination results were collected and statistically analyzed as case group in 128 elderly patients with goiter and hyperthyroidism. Additional 128 over 60-year-old patients with hyperthyroidism were selected as control group. The thyroid tissue of these patients and the control group were examined by fine needle aspiration biopsy. The expressions of IL-2, IL-6, TGF-β of the thyroid tissue in all patients were detected by immunohistochemistry, qRT-PCR (Real-time Quantitative Polymerase Chain Reaction) and Western blot method respectively, and the statistical analysis was carried out. p < 0.05 indicated that the difference had statistical significance.
RESULTS: Compared with the control group, the expressions of IL-2, IL-6 and TGF-β in the group of patients were significantly higher (p < 0.05). The significantly higher expression of IL-2, IL-6, and TGF-β was mainly concentrated in the thyroid follicular cells of patients with hyperthyroidism and thyroid enlargement (p < 0.05). In the patients with goiter, hyperthyroidism, and symptoms of exophthalmos, the level of expression of IL-6 was significantly higher than that of patients without exophthalmos (p < 0.05). In the patients with goiter, hyperthyroidism and symptoms of exophthalmos, and the patients with goiter, hyperthyroidism without symptoms of exophthalmos, IL-2 and TGF-β expression level were not different (p > 0.05).
CONCLUSIONS: The expression levels of IL-2, IL-6, and TGF-β were significantly increased in the patients with senile goiter and hyperthyroidism, but in the senile patients with goiter, hyperthyroidism and exophthalmos symptoms, IL-6 levels were significantly higher than those without exophthalmos. The use of IL-2, IL-6, and TGF-β is of great significance in the diagnosis of goiter with hyperthyroidism, especially for elderly patients with atypical clinical symptoms of hyperthyroidism.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29131274

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  8 in total

1.  Changes in bone mineral density, 25-hydroxyvitamin D3 and inflammatory factors in patients with hyperthyroidism.

Authors:  Yali Zhou; Xixia Wang; Maoyuan Xin; Haiting Zhuang
Journal:  Exp Ther Med       Date:  2021-04-14       Impact factor: 2.447

2.  Gene polymorphisms of pro-inflammatory cytokines may affect the risk of Graves' disease: a meta-analysis.

Authors:  P Zhu; X Wu; J Zhou; K Wu; Y Lu
Journal:  J Endocrinol Invest       Date:  2020-05-30       Impact factor: 4.256

Review 3.  The role of transforming growth factor beta in thyroid autoimmunity: current knowledge and future perspectives.

Authors:  Efstratios Kardalas; Evangelos Sakkas; Marek Ruchala; Djuro Macut; George Mastorakos
Journal:  Rev Endocr Metab Disord       Date:  2021-09-16       Impact factor: 6.514

Review 4.  TGF-β Physiology as a Novel Therapeutic Target Regarding Autoimmune Thyroid Diseases: Where Do We Stand and What to Expect.

Authors:  Efstratios Kardalas; Spyridoula Maraka; Maria Papagianni; George Paltoglou; Charalampos Siristatidis; George Mastorakos
Journal:  Medicina (Kaunas)       Date:  2021-06-14       Impact factor: 2.430

Review 5.  Association between Thyroid Disease and Severe Coronavirus Disease 2019 (COVID-19) Infection: A Meta-Analysis.

Authors:  Juan Xu; Yang Li; Quansong Xia; Qiong Shi
Journal:  Iran J Public Health       Date:  2021-08       Impact factor: 1.429

6.  Thyroid Dysfunction in COVID-19.

Authors:  Aashima Dabas; Harpreet Singh; Binita Goswami; Kunal Kumar; Abhishek Dubey; Urmila Jhamb; Sangeeta Yadav; Sandeep Garg
Journal:  Indian J Endocrinol Metab       Date:  2021-10-26

Review 7.  SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Graves' disease.

Authors:  Avaniyapuram Kannan Murugan; Ali S Alzahrani
Journal:  Endocrine       Date:  2021-06-09       Impact factor: 3.633

Review 8.  Risk factors, treatment and outcomes of subacute thyroiditis secondary to COVID-19: a systematic review.

Authors:  Jacob Christensen; Kevin O'Callaghan; Holly Sinclair; Kate Hawke; Amanda Love; Krispin Hajkowicz; Adam G Stewart
Journal:  Intern Med J       Date:  2022-04       Impact factor: 2.611

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.